{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:30:41Z","timestamp":1790685041623,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA142969"],"award-info":[{"award-number":["R01CA142969"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA195686"],"award-info":[{"award-number":["R01CA195686"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01-CA206539"],"award-info":[{"award-number":["R01-CA206539"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA236905"],"award-info":[{"award-number":["R01CA236905"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA236905"],"award-info":[{"award-number":["R01CA236905"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R03CA235106"],"award-info":[{"award-number":["R03CA235106"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["K08CA234222"],"award-info":[{"award-number":["K08CA234222"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA266223"],"award-info":[{"award-number":["R01CA266223"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Pancreatic intraepithelial neoplasia (PanIN) is a precursor of pancreatic ductal adenocarcinoma (PDAC), which commonly occurs in the general populations with aging. Although most PanIN lesions (PanINs) harbor oncogenic\n                    <jats:italic>KRAS<\/jats:italic>\n                    mutations that initiate pancreatic tumorigenesis; PanINs rarely progress to PDAC. Critical factors that promote this progression, especially targetable ones, remain poorly defined. We show that peroxisome proliferator-activated receptor-delta (PPAR\u03b4), a lipid nuclear receptor, is upregulated in PanINs in humans and mice. Furthermore, PPAR\u03b4 ligand activation by a high-fat diet or GW501516 (a highly selective, synthetic PPAR\u03b4 ligand) in mutant\n                    <jats:italic>KRAS<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>G12D<\/jats:italic>\n                    <\/jats:sup>\n                    (\n                    <jats:italic>KRAS<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>mu<\/jats:italic>\n                    <\/jats:sup>\n                    ) pancreatic epithelial cells strongly accelerates PanIN progression to PDAC. This PPAR\u03b4 activation induces\n                    <jats:italic>KRAS<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>mu<\/jats:italic>\n                    <\/jats:sup>\n                    pancreatic epithelial cells to secrete CCL2, which recruits immunosuppressive macrophages and myeloid-derived suppressor cells into pancreas via the CCL2\/CCR2 axis to orchestrate an immunosuppressive tumor microenvironment and subsequently drive PanIN progression to PDAC. Our data identify PPAR\u03b4 signaling as a potential molecular target to prevent PDAC development in subjects harboring PanINs.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-30392-7","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T06:05:35Z","timestamp":1652421935000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPAR\u03b4"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9748-0650","authenticated-orcid":false,"given":"Yi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoyan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheline J.","family":"Moussalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2038-5863","authenticated-orcid":false,"given":"Huamin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lovie Ann","family":"Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Colby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5398-0802","authenticated-orcid":false,"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0616-2310","authenticated-orcid":false,"given":"Haoqiang","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2399-1375","authenticated-orcid":false,"given":"Mihai","family":"Gagea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4893-1587","authenticated-orcid":false,"given":"Jiaqi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8593-1132","authenticated-orcid":false,"given":"Xiangsheng","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2019-938X","authenticated-orcid":false,"given":"Imad","family":"Shureiqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,13]]},"reference":[{"key":"30392_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","volume":"388","author":"T Kamisawa","year":"2016","unstructured":"Kamisawa, T., Wood, L. D., Itoi, T. & Takaori, K. Pancreatic cancer. Lancet 388, 73\u201385 (2016).","journal-title":"Lancet"},{"key":"30392_CR2","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/00000478-200105000-00003","volume":"25","author":"RH Hruban","year":"2001","unstructured":"Hruban, R. H. et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am. J. Surg. Pathol. 25, 579\u2013586 (2001).","journal-title":"Am. J. Surg. Pathol."},{"key":"30392_CR3","doi-asserted-by":"crossref","unstructured":"Matsuda, Y. et al. The prevalence and clinicopathological characteristics of high-grade pancreatic intraepithelial neoplasia: autopsy study evaluating the entire pancreatic parenchyma. Pancreas 46, 658\u2013664 (2017).","DOI":"10.1097\/MPA.0000000000000786"},{"key":"30392_CR4","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1097\/01.MP.0000087422.24733.62","volume":"16","author":"A Andea","year":"2003","unstructured":"Andea, A., Sarkar, F. & Adsay, V. N. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Mod. Pathol. 16, 996\u20131006 (2003).","journal-title":"Mod. Pathol."},{"key":"30392_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41575-021-00470-0","volume":"18","author":"AD Singhi","year":"2021","unstructured":"Singhi, A. D. & Wood, L. D. Early detection of pancreatic cancer using DNA-based molecular approaches. Nat. Rev. Gastroenterol. Hepatol. 18, 457\u2013468 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"30392_CR6","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1053\/j.gastro.2011.12.042","volume":"142","author":"M Kanda","year":"2012","unstructured":"Kanda, M. et al. Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia. Gastroenterology 142, 730\u2013733.e739 (2012).","journal-title":"Gastroenterology"},{"key":"30392_CR7","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1053\/j.gastro.2013.01.071","volume":"144","author":"MP di Magliano","year":"2013","unstructured":"di Magliano, M. P. & Logsdon, C. D. Roles for KRAS in pancreatic tumor development and progression. Gastroenterology 144, 1220\u20131229 (2013).","journal-title":"Gastroenterology"},{"key":"30392_CR8","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1093\/jnci\/dji292","volume":"97","author":"U N\u00f6thlings","year":"2005","unstructured":"N\u00f6thlings, U. et al. Meat and fat intake as risk factors for pancreatic cancer: the multiethnic cohort study. J. Natl Cancer Inst. 97, 1458\u20131465 (2005).","journal-title":"J. Natl Cancer Inst."},{"key":"30392_CR9","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/jnci\/djp168","volume":"101","author":"AC Thi\u00e9baut","year":"2009","unstructured":"Thi\u00e9baut, A. C. et al. Dietary fatty acids and pancreatic cancer in the NIH-AARP diet and health study. J. Natl Cancer Inst. 101, 1001\u20131011 (2009).","journal-title":"J. Natl Cancer Inst."},{"key":"30392_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/aje\/kwx036","volume":"186","author":"VLZ Gordon-Dseagu","year":"2017","unstructured":"Gordon-Dseagu, V. L. Z. et al. A cohort study of adolescent and midlife diet and pancreatic cancer risk in the nIH-AARP diet and health study. Am. J. Epidemiol. 186, 305\u2013317 (2017).","journal-title":"Am. J. Epidemiol."},{"key":"30392_CR11","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1097\/MPA.0b013e318220e742","volume":"40","author":"M Hori","year":"2011","unstructured":"Hori, M. et al. Enhancement of carcinogenesis and fatty infiltration in the pancreas in N-nitrosobis(2-oxopropyl)amine-treated hamsters by high-fat diet. Pancreas 40, 1234\u20131240 (2011).","journal-title":"Pancreas"},{"key":"30392_CR12","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1053\/j.gastro.2013.08.018","volume":"145","author":"B Philip","year":"2013","unstructured":"Philip, B. et al. A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. Gastroenterology 145, 1449\u20131458 (2013).","journal-title":"Gastroenterology"},{"key":"30392_CR13","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1073\/pnas.0802864106","volume":"106","author":"J Khasawneh","year":"2009","unstructured":"Khasawneh, J. et al. Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion. Proc. Natl Acad. Sci. USA 106, 3354\u20133359 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"30392_CR14","doi-asserted-by":"publisher","first-page":"e0184455","DOI":"10.1371\/journal.pone.0184455","volume":"12","author":"HH Chang","year":"2017","unstructured":"Chang, H. H. et al. Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice. PLoS ONE 12, e0184455 (2017).","journal-title":"PLoS ONE"},{"key":"30392_CR15","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1158\/1940-6207.CAPR-13-0065","volume":"6","author":"DW Dawson","year":"2013","unstructured":"Dawson, D. W. et al. High-fat, high-calorie diet promotes early pancreatic neoplasia in the conditional KrasG12D mouse model. Cancer Prev. Res. (Philos.) 6, 1064\u20131073 (2013).","journal-title":"Cancer Prev. Res. (Philos.)"},{"key":"30392_CR16","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1053\/j.gastro.2019.07.030","volume":"157","author":"Y Luo","year":"2019","unstructured":"Luo, Y. et al. Oncogenic KRAS reduces expression of FGF21 in acinar cells to promote pancreatic tumorigenesis in mice on a high-fat diet. Gastroenterology 157, 1413\u20131428 e1411 (2019).","journal-title":"Gastroenterology"},{"key":"30392_CR17","doi-asserted-by":"publisher","first-page":"G699","DOI":"10.1152\/ajpgi.00123.2018","volume":"315","author":"S Nadella","year":"2018","unstructured":"Nadella, S. et al. Dietary fat stimulates pancreatic cancer growth and promotes fibrosis of the tumor microenvironment through the cholecystokinin receptor. Am. J. Physiol. Gastrointest. Liver Physiol. 315, G699\u2013G712 (2018).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"30392_CR18","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1111\/cas.13766","volume":"109","author":"M Takahashi","year":"2018","unstructured":"Takahashi, M. et al. Fatty pancreas: a possible risk factor for pancreatic cancer in animals and humans. Cancer Sci. 109, 3013\u20133023 (2018).","journal-title":"Cancer Sci."},{"key":"30392_CR19","doi-asserted-by":"crossref","unstructured":"Liu, Y. et al. The role of PPAR-delta in metabolism, inflammation, and cancer: many characters of a critical transcription factor. Int. J. Mol. Sci. 19, 3339 (2018).","DOI":"10.3390\/ijms19113339"},{"key":"30392_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0092-8674(00)81664-5","volume":"99","author":"TC He","year":"1999","unstructured":"He, T. C., Chan, T. A., Vogelstein, B. & Kinzler, K. W. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99, 335\u2013345 (1999).","journal-title":"Cell"},{"key":"30392_CR21","doi-asserted-by":"publisher","first-page":"13275","DOI":"10.1073\/pnas.97.24.13275","volume":"97","author":"RA Gupta","year":"2000","unstructured":"Gupta, R. A. et al. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer. Proc. Natl Acad. Sci. USA 97, 13275\u201313280 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"30392_CR22","doi-asserted-by":"publisher","first-page":"12890","DOI":"10.1073\/pnas.0705505104","volume":"104","author":"A Abdollahi","year":"2007","unstructured":"Abdollahi, A. et al. Transcriptional network governing the angiogenic switch in human pancreatic cancer. Proc. Natl Acad. Sci. USA 104, 12890\u201312895 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"30392_CR23","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1165\/rcmb.2007-0426OC","volume":"39","author":"TV Pedchenko","year":"2008","unstructured":"Pedchenko, T. V., Gonzalez, A. L., Wang, D., DuBois, R. N. & Massion, P. P. Peroxisome proliferator-activated receptor \u03b2\/\u03b4 expression and activation in lung cancer. Am. J. Respir. Cell Mol. Biol. 39, 689\u2013696 (2008).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"30392_CR24","doi-asserted-by":"publisher","first-page":"e91419","DOI":"10.1172\/jci.insight.91419","volume":"2","author":"X Zuo","year":"2017","unstructured":"Zuo, X. et al. Metastasis regulation by PPARD expression in cancer cells. JCI Insight 2, e91419 (2017).","journal-title":"JCI Insight"},{"key":"30392_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1155\/2013\/121956","volume":"2013","author":"JD Coleman","year":"2013","unstructured":"Coleman, J. D., Thompson, J. T., Smith, R. W., Prokopczyk, B. & Vanden Heuvel, J. P. Role of peroxisome proliferator-activated receptor and B-cell lymphoma-6 in regulation of genes involved in metastasis and migration in pancreatic cancer cells. PPAR Res. 2013, 11 (2013).","journal-title":"PPAR Res."},{"key":"30392_CR26","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.atherosclerosis.2011.10.029","volume":"220","author":"YJ Choi","year":"2012","unstructured":"Choi, Y. J. et al. Effects of the PPAR-delta agonist MBX-8025 on atherogenic dyslipidemia. Atherosclerosis 220, 470\u2013476 (2012).","journal-title":"Atherosclerosis"},{"key":"30392_CR27","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2337\/db07-1318","volume":"57","author":"U Ris\u00e9rus","year":"2008","unstructured":"Ris\u00e9rus, U. et al. Activation of peroxisome proliferator\u2013activated receptor (PPAR)\u03b4 promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men. Diabetes 57, 332\u2013339 (2008).","journal-title":"Diabetes"},{"key":"30392_CR28","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","volume":"4","author":"SR Hingorani","year":"2003","unstructured":"Hingorani, S. R. et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437\u2013450 (2003).","journal-title":"Cancer Cell"},{"key":"30392_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1817-3","volume":"17","author":"F Grizzi","year":"2019","unstructured":"Grizzi, F. et al. Computer-aided assessment of the extra-cellular matrix during pancreatic carcinogenesis: a pilot study. J. Transl. Med. 17, 61 (2019).","journal-title":"J. Transl. Med."},{"key":"30392_CR30","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","volume":"149","author":"H Ying","year":"2012","unstructured":"Ying, H. et al. Oncogenic kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell 149, 656\u2013670 (2012).","journal-title":"Cell"},{"key":"30392_CR31","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.1038\/onc.2012.549","volume":"32","author":"T Adhikary","year":"2013","unstructured":"Adhikary, T. et al. Inverse PPAR\u03b2\/\u03b4 agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion. Oncogene 32, 5241\u20135252 (2013).","journal-title":"Oncogene"},{"key":"30392_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1073\/pnas.012610299","volume":"99","author":"Y Barak","year":"2002","unstructured":"Barak, Y. et al. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc. Natl Acad. Sci. USA 99, 303\u2013308 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"30392_CR33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nm993","volume":"10","author":"RA Gupta","year":"2004","unstructured":"Gupta, R. A. et al. Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth. Nat. Med. 10, 245\u2013247 (2004).","journal-title":"Nat. Med."},{"key":"30392_CR34","doi-asserted-by":"publisher","first-page":"6359","DOI":"10.1158\/0008-5472.CAN-13-1558-T","volume":"73","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance. Cancer Res. 73, 6359\u20136374 (2013).","journal-title":"Cancer Res."},{"key":"30392_CR35","doi-asserted-by":"publisher","first-page":"5020","DOI":"10.1158\/0008-5472.CAN-11-0908","volume":"71","author":"RB Corcoran","year":"2011","unstructured":"Corcoran, R. B. et al. STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis. Cancer Res. 71, 5020\u20135029 (2011).","journal-title":"Cancer Res."},{"key":"30392_CR36","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1053\/j.gastro.2009.05.052","volume":"137","author":"B Ji","year":"2009","unstructured":"Ji, B. et al. Ras activity levels control the development of pancreatic diseases. Gastroenterology 137, 1072\u20131082 (2009). 1082.e1071-1076.","journal-title":"Gastroenterology"},{"key":"30392_CR37","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/onc.2012.619","volume":"33","author":"H Huang","year":"2014","unstructured":"Huang, H. et al. Oncogenic K-Ras requires activation for enhanced activity. Oncogene 33, 532\u2013535 (2014).","journal-title":"Oncogene"},{"key":"30392_CR38","doi-asserted-by":"crossref","unstructured":"Veglia, F. et al. Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice. J. Exp. Med. 218, e20201803 (2021).","DOI":"10.1084\/jem.20201803"},{"key":"30392_CR39","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1016\/j.celrep.2016.04.084","volume":"15","author":"AM Georgoudaki","year":"2016","unstructured":"Georgoudaki, A. M. et al. Reprogramming tumor-associated macrophages by antibody targeting inhibits cancer progression and metastasis. Cell Rep. 15, 2000\u20132011 (2016).","journal-title":"Cell Rep."},{"key":"30392_CR40","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1158\/0008-5472.CAN-09-4672","volume":"70","author":"K Movahedi","year":"2010","unstructured":"Movahedi, K. et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 70, 5728\u20135739 (2010).","journal-title":"Cancer Res."},{"key":"30392_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1053\/j.gastro.2019.03.018","volume":"157","author":"X Zuo","year":"2019","unstructured":"Zuo, X. et al. PPARD and interferon gamma promote transformation of gastric progenitor cells and tumorigenesis in mice. Gastroenterology 157, 163\u2013178 (2019).","journal-title":"Gastroenterology"},{"key":"30392_CR42","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.cell.2017.07.007","volume":"170","author":"JS Roe","year":"2017","unstructured":"Roe, J. S. et al. Enhancer reprogramming promotes pancreatic cancer metastasis. Cell 170, 875\u2013888.e820 (2017).","journal-title":"Cell"},{"key":"30392_CR43","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1158\/1078-0432.CCR-13-0525","volume":"19","author":"DE Sanford","year":"2013","unstructured":"Sanford, D. E. et al. Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2\/CCR2 axis. Clin. Cancer Res. 19, 3404\u20133415 (2013).","journal-title":"Clin. Cancer Res."},{"key":"30392_CR44","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1073\/pnas.1910856117","volume":"117","author":"JA Flores-Toro","year":"2020","unstructured":"Flores-Toro, J. A. et al. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas. Proc. Natl Acad. Sci. USA 117, 1129\u20131138 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"30392_CR45","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1158\/2159-8290.CD-19-0597","volume":"10","author":"P Hou","year":"2020","unstructured":"Hou, P. et al. Tumor microenvironment remodeling enables bypass of oncogenic KRAS dependency in pancreatic cancer. Cancer Disco. 10, 1058\u20131077 (2020).","journal-title":"Cancer Disco."},{"key":"30392_CR46","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1158\/0008-5472.CAN-12-2731","volume":"73","author":"JB Mitchem","year":"2013","unstructured":"Mitchem, J. B. et al. Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. Cancer Res. 73, 1128\u20131141 (2013).","journal-title":"Cancer Res."},{"key":"30392_CR47","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1021\/ml200199c","volume":"2","author":"CB Xue","year":"2011","unstructured":"Xue, C. B. et al. Discovery of INCB8761\/PF-4136309, a potent, selective, and orally bioavailable CCR2 antagonist. ACS Med. Chem. Lett. 2, 913\u2013918 (2011).","journal-title":"ACS Med. Chem. Lett."},{"key":"30392_CR48","first-page":"3282","volume":"62","author":"J Shao","year":"2002","unstructured":"Shao, J., Sheng, H. & DuBois, R. N. Peroxisome proliferator-activated receptors modulate K-Ras-mediated transformation of intestinal epithelial cells. Cancer Res. 62, 3282\u20133288 (2002).","journal-title":"Cancer Res."},{"key":"30392_CR49","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1365-2613.2009.00667.x","volume":"90","author":"F Luo","year":"2009","unstructured":"Luo, F. et al. Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways. Int J. Exp. Pathol. 90, 558\u2013574 (2009).","journal-title":"Int J. Exp. Pathol."},{"key":"30392_CR50","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1053\/gast.1996.v110.pm8536861","volume":"110","author":"M Tada","year":"1996","unstructured":"Tada, M. et al. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 110, 227\u2013231 (1996).","journal-title":"Gastroenterology"},{"key":"30392_CR51","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1096\/fj.14-264515","volume":"29","author":"F Mao","year":"2015","unstructured":"Mao, F. et al. 15-Lipoxygenase-1 suppression of colitis-associated colon cancer through inhibition of the IL-6\/STAT3 signaling pathway. FASEB J. 29, 2359\u20132370 (2015).","journal-title":"FASEB J."},{"key":"30392_CR52","doi-asserted-by":"publisher","first-page":"7084","DOI":"10.1073\/pnas.1324233111","volume":"111","author":"D Wang","year":"2014","unstructured":"Wang, D. et al. Peroxisome proliferator-activated receptor delta promotes colonic inflammation and tumor growth. Proc. Natl Acad. Sci. USA 111, 7084\u20137089 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"30392_CR53","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1101\/gad.275776.115","volume":"30","author":"H Ying","year":"2016","unstructured":"Ying, H. et al. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 30, 355\u2013385 (2016).","journal-title":"Genes Dev."},{"key":"30392_CR54","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1136\/gutjnl-2013-306271","volume":"63","author":"IM Stromnes","year":"2014","unstructured":"Stromnes, I. M. et al. Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity. Gut 63, 1769\u20131781 (2014).","journal-title":"Gut"},{"key":"30392_CR55","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ccr.2012.04.025","volume":"21","author":"LJ Bayne","year":"2012","unstructured":"Bayne, L. J. et al. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 21, 822\u2013835 (2012).","journal-title":"Cancer Cell"},{"key":"30392_CR56","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.molimm.2019.11.014","volume":"117","author":"BH Li","year":"2020","unstructured":"Li, B. H., Garstka, M. A. & Li, Z. F. Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor. Mol. Immunol. 117, 201\u2013215 (2020).","journal-title":"Mol. Immunol."},{"key":"30392_CR57","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1053\/j.gastro.2012.09.059","volume":"144","author":"H Huang","year":"2013","unstructured":"Huang, H. et al. Activation of nuclear factor-kappaB in acinar cells increases the severity of pancreatitis in mice. Gastroenterology 144, 202\u2013210 (2013).","journal-title":"Gastroenterology"},{"key":"30392_CR58","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1172\/JCI59743","volume":"122","author":"J Daniluk","year":"2012","unstructured":"Daniluk, J. et al. An NF-kappaB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice. J. Clin. Invest. 122, 1519\u20131528 (2012).","journal-title":"J. Clin. Invest."},{"key":"30392_CR59","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccell.2016.02.005","volume":"29","author":"D Wei","year":"2016","unstructured":"Wei, D. et al. KLF4 is essential for induction of cellular identity change and acinar-to-ductal reprogramming during early pancreatic carcinogenesis. Cancer Cell 29, 324\u2013338 (2016).","journal-title":"Cancer Cell"},{"key":"30392_CR60","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/path.1515","volume":"202","author":"E Charafe-Jauffret","year":"2004","unstructured":"Charafe-Jauffret, E. et al. Immunophenotypic analysis of inflammatory breast cancers: identification of an \u2018inflammatory signature\u2019. J. Pathol. 202, 265\u2013273 (2004).","journal-title":"J. Pathol."},{"key":"30392_CR61","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1158\/0008-5472.CAN-18-1790","volume":"79","author":"Y Liu","year":"2019","unstructured":"Liu, Y. et al. Pleiotropic effects of PPARD accelerate colorectal tumorigenesis, progression, and invasion. Cancer Res. 79, 954\u2013969 (2019).","journal-title":"Cancer Res."},{"key":"30392_CR62","first-page":"8367063","volume":"2016","author":"Z Yan","year":"2016","unstructured":"Yan, Z. et al. Quantitative evaluation and selection of reference genes for quantitative RT-PCR in mouse acute pancreatitis. Biomed. Res. Int. 2016, 8367063 (2016).","journal-title":"Biomed. Res. Int."},{"key":"30392_CR63","first-page":"2016","volume":"55","author":"L Badea","year":"2008","unstructured":"Badea, L., Herlea, V., Dima, S. O., Dumitrascu, T. & Popescu, I. Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology 55, 2016\u20132027 (2008).","journal-title":"Hepatogastroenterology"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30392-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30392-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30392-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T12:18:19Z","timestamp":1669292299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30392-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,13]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["30392"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-30392-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,13]]},"assertion":[{"value":"27 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2665"}}